US, Europe and Japan Tumor Marker Testing Markets Analyzed in Updated Reports Published by MarketPublishers.com
19 Sep 2011 • by Natalie Aster
LONDON - Market Publishers Ltd informs that updated in-demand Venture Planning Group analyses on US, European and Japanese tumor marker testing markets have been added to its catalogue.
These updated reports provide true and unbiased insights into the US, Europe (France, Germany, Italy, Spain, UK) and Japan testing markets for various tumor markers. Each study contains clinical significance and current laboratory practice, five- and ten-year test volume and sales forecasts by country and market segment, as well as sales and market shares for major suppliers. Market applications of various technologies, operating characteristics of automated analyzers, profiles of top suppliers and recent market entrants, as well as alternative strategies for market penetration can also be found in each analysis.
The list of updated tumor marker testing market analyses comprises:
- The 2011 CA Tumor Markers: US, Europe, Japan - Test Volume, Sales Forecasts and Supplier Shares by Country
- The 2011 AFP Testing Market: US, Europe, Japan - Test Volume, Sales Forecasts and Supplier Shares by Country
- The 2011 Beta-2 Microglobulin Testing Market: US, Europe, Japan - Test Volume, Sales Forecasts and Supplier Shares
- The 2011 CEA Testing Market: US, Europe, Japan - Test Volume, Sales Forecasts and Supplier Shares by Country
- The 2011 Prostatic Acid Phosphatase Testing Market: US, Europe, Japan - Test Volume, Sales Forecasts and Supplier Shares
More updated and new publisher’s market research reports can be found at Venture Planning Group page.
CONTACTS
The Market Publishers, Ltd.
Tanya Rezler
Tel: +44 208 123 2220
Fax: +44 207 900 3970
Analytics & News
